The characteristics of metabolic syndrome that may favor cancer formation and create a pro-oncogenic status include increased proinflammatory cytokine status [20,31], adipokine regulation imbalance [32,33], hormonal dysregulation including hyperestrogenism [34], disturbances to tissue microenvironment, insulin resistance, and hyperinsulinemia [35]. The gene discussed is INS; the disease is cancer.